Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $0.38, $0.16 better than the analyst estimate of $0.22. Revenue for the quarter came in at $445.6 million versus the consensus estimate of $433.83 million.

GUIDANCE:

Nu Skin Enterprises sees Q1 2025 revenue of $345-365 million, versus the consensus of $404 million.

Q1 2025 Revenue	$345 to $365 million; (17)% to (13)% Approximately (3)% FX impact
Q1 2025 EPS	$2.65 to $2.75 or $0.10 to $0.20 excluding the gain from the Mavely transaction
2025 Revenue	$1.48 to $1.62 billion; (15)% to (6)% or (11)% to (3)% excluding Mavely revenue in 2024 Approximately (3)% FX impact
2025 EPS	$3.45 to $3.85 or $0.90 to $1.30 excluding the gain from the Mavely transaction

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.